Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
UltraEZ for Sensitivity During At-Home Bleaching
NCT06371092Phase 1Completed
- Sponsor
- Universidad de Santiago de Compostela
- Start
- Jan 2023
- Primary completion
- Feb 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, triple-blind trial in dentin hypersensitivity (DH) comparing UltraEZ Group with Placebo Group (2 arms). Primary endpoint: Questionnaire of dental sensitivity at 3 weeks. Started Jan 2023; status: completed.
02
Drugs
UltraEZ
03
Conditions
dentin hypersensitivity (DH)
Beyond the preview
Go deeper on NCT06371092.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06371092.